Thursday, July 9, 2026

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

WAR IS COMING: North Korea Built a Forward Operating Base Directly on the South’s Border

North Korea's military incursions across the MDL have surged, prompting South Korea to propose talks amid rising tensions and risks of clashes.

Coupang Controversy: Will U.S. Intervention Spark a Trade War Between Korea and America?

U.S. investors demand U.S. intervention in Coupang's data breach, alleging South Korea's discrimination, which could escalate trade tensions.

Tag: GI-101A

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.